Granahan Investment Management, LLC Castle Biosciences Inc Transaction History

Granahan Investment Management, LLC

$2.38 Billion
Q3 2024

A detailed history of Granahan Investment Management, LLC transactions in Castle Biosciences Inc stock. As of the latest transaction made, Granahan Investment Management, LLC holds 425,220 shares of CSTL stock, worth $11.7 Million. This represents 0.51% of its overall portfolio holdings.

Number of Shares

425,220

Previous 1,058,941 59.84%

Holding current value

$11.7 Million

Previous $23.1 Million 47.4%

% of portfolio

0.51%

Previous 0.97%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$17.4 - $31.47 $11 Million - $19.9 Million	-633,721 Reduced 59.84%	425,220 $12.1 Million
Q2 2024 Aug 14, 2024	SELL	$18.84 - $24.94 $10.7 Million - $14.2 Million	-568,283 Reduced 34.92%	1,058,941 $23.1 Million
Q1 2024 May 15, 2024	SELL	$18.06 - $25.3 $9.74 Million - $13.6 Million	-539,247 Reduced 24.89%	1,627,224 $36 Million
Q4 2023 Feb 14, 2024	SELL	$12.19 - $22.43 $3.92 Million - $7.2 Million	-321,202 Reduced 12.91%	2,166,471 $46.8 Million
Q3 2023 Nov 14, 2023	SELL	$13.28 - $20.3 $554,546 - $847,687	-41,758 Reduced 1.65%	2,487,673 $42 Million
Q2 2023 Aug 14, 2023	BUY	$11.66 - $26.0 $15.5 Million - $34.6 Million	1,329,382 Added 110.78%	2,529,431 $34.7 Million
Q1 2023 May 15, 2023	BUY	$19.47 - $28.49 $3.03 Million - $4.44 Million	155,721 Added 14.91%	1,200,049 $27.3 Million
Q4 2022 Feb 14, 2023	BUY	$18.08 - $30.0 $5.1 Million - $8.46 Million	282,111 Added 37.01%	1,044,328 $24.6 Million
Q3 2022 Nov 14, 2022	SELL	$22.51 - $34.32 $3.25 Million - $4.96 Million	-144,547 Reduced 15.94%	762,217 $19.9 Million
Q2 2022 Aug 15, 2022	BUY	$16.0 - $45.99 $1.81 Million - $5.2 Million	113,049 Added 14.24%	906,764 $19.9 Million
Q1 2022 May 16, 2022	BUY	$33.17 - $46.98 $1.87 Million - $2.65 Million	56,341 Added 7.64%	793,715 $35.6 Million
Q4 2021 Feb 14, 2022	BUY	$39.06 - $67.58 $11.2 Million - $19.4 Million	286,394 Added 63.5%	737,374 $31.6 Million
Q3 2021 Nov 15, 2021	BUY	$60.13 - $77.6 $381,885 - $492,837	6,351 Added 1.43%	450,980 $30 Million
Q2 2021 Aug 16, 2021	BUY	$50.07 - $76.78 $8.03 Million - $12.3 Million	160,408 Added 56.44%	444,629 $32.6 Million
Q1 2021 May 17, 2021	BUY	$58.92 - $97.33 $3.37 Million - $5.57 Million	57,233 Added 25.21%	284,221 $19.5 Million
Q4 2020 Feb 12, 2021	SELL	$43.6 - $73.05 $6.14 Million - $10.3 Million	-140,897 Reduced 38.3%	226,988 $15.2 Million
Q3 2020 Nov 12, 2020	BUY	$38.47 - $52.03 $3.55 Million - $4.8 Million	92,255 Added 33.47%	367,885 $18.9 Million
Q2 2020 Aug 14, 2020	BUY	$27.28 - $43.01 $6.41 Million - $10.1 Million	234,900 Added 576.72%	275,630 $10.4 Million
Q1 2020 May 12, 2020	SELL	$23.08 - $35.53 $280,029 - $431,085	-12,133 Reduced 22.95%	40,730 $1.21 Million
Q4 2019 Feb 14, 2020	BUY	$15.74 - $35.04 $832,063 - $1.85 Million	52,863 New	52,863 $1.82 Million

Others Institutions Holding CSTL

# of Institutions

201

Shares Held

24.5M

Call Options Held

303K

Put Options Held

30.3K

View Full List

About CASTLE BIOSCIENCES INC

Ticker CSTL
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 26,297,000
Market Cap $724M
Description
Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...

More about CSTL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Granahan Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Granahan Investment Management, LLC with notifications on news.

Account

Granahan Investment Management, LLC Castle Biosciences Inc Transaction History